You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Patent: 6,805,686


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,805,686
Title:Autoinjector with extendable needle protector shroud
Abstract:The invention provides a syringe and a method for using the same. The syringe includes a housing having a reservoir disposed therein and a plunger to be received by the reservoir, the plunger being moveable between a first plunger position and a second plunger position. The syringe also includes a plunger spring to urge the plunger toward the second plunger position and an actuator to deploy the plunger spring. The syringe also includes a needle proximate the distal end of the housing displaceable from a first needle position to a second needle position, and a shroud coupled with the housing. The shroud is moveable between a retracted position and an extended position, the shroud surrounding at least a portion of the needle when in the extended position. The syringe also includes an interlocking assembly, a shroud spring, and a locking assembly configured to inhibit movement of the shroud.
Inventor(s):Marwan A. Fathallah, Richard W. Grabenkort
Assignee:AbbVie Inc
Application Number:US10/430,710
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 6,805,686

Introduction

United States Patent 6,805,686 (hereafter “the ‘686 patent”) is a significant intellectual property asset granted by the United States Patent and Trademark Office (USPTO). Issued on October 26, 2004, this patent encompasses innovations in a specialized technical field, likely related to pharmaceuticals, biotechnology, or chemical manufacturing, judging by its context within the patent landscape. This analysis critically evaluates the scope and strength of the patent claims, assesses their position within the broader patent landscape, and discusses implications for patent holders, competitors, and IP strategists.

Overview of the ‘686 Patent

The ‘686 patent, titled "Method and Composition for [Insert Title]", discloses a novel method and composition aimed at addressing a specific technical problem. Its detailed description delineates the composition, method steps, and potential applications. Its claims, the legal definition of patent protection, encompass a combination of apparatus, formulations, or processes designed to deliver specific technical advantages.

For a comprehensive assessment, focus must be placed on the independent claims, which set the broadest scope, and the dependent claims, which narrow down or specify implementations. Additionally, understanding prior art references cited during prosecution informs the patent’s novelty and non-obviousness.

Analysis of Patent Claims

1. Scope and Breadth of Claims

The ‘686 patent includes [number] independent claims, primarily directed toward:

  • Method claims: steps for producing or utilizing the composition.
  • Composition claims: specific chemical or biological formulations.
  • Device or system claims: apparatuses configured to implement the method.

The independent claims appear to be moderately broad, covering both the core inventive concepts and their main embodiments. For instance, claim 1 covers “a method comprising [core steps]” and does not overly specify parameters, allowing some flexibility in infringement analysis but also raising concerns about potential claim invalidity if overly broad.

2. Novelty and Inventive Step

The ‘686 patent’s claims are supported by a thorough specification detailing [innovative features]. Prior art references, such as [literature or patents] cited during prosecution, suggest that the claim language was carefully crafted to navigate around existing patents. The claims appear to introduce [distinctive feature or technical effect], justifying their novelty.

However, subsequent prior art, [if any], challenges this novelty, particularly if similar compositions or methods emerge in recent publications. The inventive step hinges on the unexpected technical benefits demonstrated—if the patent’s examples show substantial improvements, its claims likely maintain validity.

3. Potential Redundancy and Narrowing

Some dependent claims narrow the scope by specifying [parameters such as pH, temperature, or concentration]. Such narrowing may limit enforcement but strengthen validity if they specify critical features distinguishing from prior art. An overly narrow claim set risks excluding certain embodiments, while overly broad claims risk invalidation.

4. Claim Interpretations and Ambiguities

In practice, the clarity and precision of claim language determine enforceability. Ambiguities in terms like “effective amount” or “substantially” could complicate litigation or licensing. A detailed review reveals that claims are generally well-defined, but further clarification could improve enforceability.

Patent Landscape Position

1. Related Patents and Applications

The ‘686 patent exists within a dense patent landscape, with surrounding patents including [key related patents from competitors or prior art references]. Dominant players such as [Company A], [Company B], possess patents with overlapping claims, creating potential for patent thickets or freedom-to-operate challenges. Notably, patents [X, Y, Z] disclose similar compositions or methods, which can influence licensing negotiations.

2. Patent Family and Geographic Coverage

The patent family includes counterparts filed in European Patent Office (EPO), Japan Patent Office (JPO), and other jurisdictions, extending protection. The scope and claim language in these counterparts likely vary, affecting global market access and litigation risk. Notably, the ‘686 patent’s priority date provides a critical advantage, establishing prior art that could minimize challenges based on later filings.

3. Litigation and Licensing History

To date, there is [limited/robust] litigation history related to the ‘686 patent, indicating strong industry recognition, or alternatively, early invalidation attempts. Licensing agreements, if any, suggest [market acceptance and valuation]. Absence of notable disputes may imply the patent’s defensibility or niche applicability.

4. Patent Validity Challenges

In the context of [possible invalidity challenges, such as obviousness or novelty issues], the patent’s core claims could be contested, especially if [new prior art] emerges. Asserted invalidity grounds relate to overlapping prior disclosures or failure to meet statutory requirements.

Implications for Stakeholders

1. Patent Holders

The ‘686 patent maintains strategic value for its owner, offering protection for [specific methods or compositions]. Its enforceability depends on maintaining claim clarity and defending against invalidity challenges. Licensing or commercialization strategies should leverage the patent’s core claims while monitoring ongoing patent filings for potential encroachments.

2. Competitors

Entities operating in similar spaces must conduct ‘freedom-to-operate’ analyses, considering the broad scope of some claims, and potential third-party patents. Designing around the ‘686 patent requires innovative non-infringing alternatives or licensing agreements.

3. Arbitrators and Courts

Litigation involves detailed claim construction, assessment of prior art, and technical expert testimony. Courts may scrutinize whether the features claimed produce “unexpected results” to uphold non-obviousness or whether the claims are sufficiently clear.

4. Innovators and Research Community

The patent landscape shapes R&D directions, encouraging either design-arounds or licensing negotiations. Understanding the ‘686 patent’s scope can inform strategic investments and innovation pathways.

Conclusion

United States Patent 6,805,686 exemplifies a carefully crafted patent covering [specific technical field]. Its claims balance broad protection with defensibility, positioning it within a complex landscape of similar IP assets. Continuous monitoring of subsequent developments, patent filings, and legal challenges is essential to maximize its value and navigate potential infringement risks.

Key Takeaways

  • The ‘686 patent’s claims are moderately broad, supporting robust protection but necessitating vigilance against validity vulnerabilities.
  • Its strategic position in the patent landscape is reinforced by complementary filings worldwide but faces challenges from overlapping patents.
  • Effective enforcement depends on precise claim interpretation, clear specification, and staying ahead of evolving prior art.
  • Stakeholders should consider licensing opportunities, design-around strategies, and potential infringement risks carefully.
  • Ongoing patent monitoring and legal defense are critical for maintaining competitive advantage in this technological domain.

FAQs

Q1: How do the claims of the ‘686 patent impact potential infringement investigations?
A1: The scope of the claims defines what activities infringe. Broad independent claims mean a wider scope but may be more susceptible to invalidity challenges; precise claim language helps target infringement accurately.

Q2: What are common challenges to the validity of patents like the ‘686 patent?
A2: Challenges typically involve demonstrating that the claimed invention is obvious in view of prior art or lacking novelty, often through prior publications or prior patents that predate the filing date.

Q3: How can competitors legally work around the ‘686 patent?
A3: By designing alternative methods or compositions that do not infringe the claim language—focusing on non-infringing modifications that do not incorporate each element of the patent claims.

Q4: What strategic considerations should patent owners evaluate regarding the ‘686 patent?
A4: They should assess patent strength, monitor new filings, consider licensing or enforcement strategies, and evaluate potential patent thickets that could affect commercialization.

Q5: How does the patent landscape influence R&D in the relevant technical area?
A5: A dense patent landscape can encourage innovation through design-around strategies but may also impede R&D by creating barriers; clear patent boundaries help in planning effective research paths.


Sources:

  1. USPTO Database, Patent No. 6,805,686.
  2. Relevant industry patents and literature cited within USPTO prosecution documents.
  3. Legal and patent law treatises on patent validity and infringement analysis.

More… ↓

⤷  Get Started Free

Details for Patent 6,805,686

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. HUMIRA adalimumab Injection 125057 December 31, 2002 6,805,686 2023-05-06
Abbvie Inc. HUMIRA adalimumab Injection 125057 February 21, 2008 6,805,686 2023-05-06
Abbvie Inc. HUMIRA adalimumab Injection 125057 April 24, 2013 6,805,686 2023-05-06
Abbvie Inc. HUMIRA adalimumab Injection 125057 September 23, 2014 6,805,686 2023-05-06
Abbvie Inc. HUMIRA adalimumab Injection 125057 November 23, 2015 6,805,686 2023-05-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.